Both molecules are incretin-based metabolic agents from Eli Lilly, but they hit a different number of receptors
Trials conducted between 2001 and 2007 demonstrated statistically significant reductions in body fat, although the larger Phase IIb OPTIONS trial did not replicate these findings at sufficient magnitude for regulatory approval, and formal development was discontinued in 2007
Our Vitamin B12 shots are here to help
Ideal Storage Store between 20C25C to preserve quality
Notably, LAbs@Lip@BMn/Rapa treatment resulted in almost negligible green fluorescence compared with LAbs@Lip@Rapa or Lip@BMn/Rapa alone treatment
increased corneal nerve fiber density Study Type 2 diabetes (2014) Design 4 mg subQ daily, 28 days Key result Improved neuropathic symptoms, HbA1c, lipids, nerve density Study Phase 2b sarcoidosis (2017) Design 64 patients, 1/4/8 mg subQ daily, 28 days Key result Met primary corneal nerve-regeneration endpoint